| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/21/2004 | CN1513472A Hypotensor composition, prepn. method and application thereof |
| 07/21/2004 | CN1513471A Injection of low molecular weight chondroitin sulfate and its prepn. method |
| 07/21/2004 | CN1513468A Compound medicine of sodium citicoline and disodium cytidine triphosphate |
| 07/21/2004 | CN1513467A Small pellet of extraction of kudzu vine, and its prepn. method |
| 07/21/2004 | CN1513466A Small pellet of Erigeron breviscapus |
| 07/21/2004 | CN1513465A Method for preparing oral prepn. contg. total flavone of kudzu vine nd said oral prepn. |
| 07/21/2004 | CN1513462A Intravenous inject contg. pseudo-ginseng total saponin and its prodn. method |
| 07/21/2004 | CN1513461A Feeze-dried powder injection contg. tatol saponin by refinement of American ginseng and leaves and stem of Americal ginseng, and its prodn. process |
| 07/21/2004 | CN1513455A prepn. for stopping vomitus contg. compound pentoxifylline |
| 07/21/2004 | CN1513453A Controlled release tablet contg. pentoxifylline |
| 07/21/2004 | CN1513451A Traditional chinese medicine Monascus purpureus went using Lovastatin salt as main active and its preparation component |
| 07/21/2004 | CN1513450A Injection of compound pancreatic alcohol |
| 07/21/2004 | CN1513449A Prepn. method for injection of ginkgolide |
| 07/21/2004 | CN1513444A Medicine for treating metaboic syndrome |
| 07/21/2004 | CN1158386C Polynucleotides isolated from skin cells and methods for their use |
| 07/21/2004 | CN1158308C Seaweed polyose product and its preparing method and use |
| 07/21/2004 | CN1158302C Arginine-aescin with functions of detumescence, relieving inflammation and improving blood circulation and its preparing process |
| 07/21/2004 | CN1158301C Soluble inorganic salt of Huanweihuangyangxing D, its preparing process and medicine conaining it |
| 07/21/2004 | CN1158297C Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/21/2004 | CN1158290C Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 07/21/2004 | CN1158279C 1-(P-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for production and utilization thereof and pharmaceutical preparations containing said compounds |
| 07/21/2004 | CN1158277C Farnesyl transferase inhibitors having piperidine structure and process for preparation thereof |
| 07/21/2004 | CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 07/21/2004 | CN1158272C Substituted benzodihydropyranyl sulfonylurea, its preparation, use in medicines and medicines containing the same |
| 07/21/2004 | CN1158266C Compounds |
| 07/21/2004 | CN1158259C Potassium channel openers |
| 07/21/2004 | CN1158258C Alpha 1 beta-adrenergic receptor antagonists |
| 07/21/2004 | CN1158257C Novel amino pyrroline compound, its prepn. method and pharmaceutical compositions contg. same |
| 07/21/2004 | CN1158103C Medicine for treating archosyrinx and its preparation method |
| 07/21/2004 | CN1158097C Medicine for treating anal disease and its prepn |
| 07/21/2004 | CN1158092C Capsule for clearing away heat and toxic material |
| 07/21/2004 | CN1158076C Thrombolytic injection for curing cerebral infarction or cerebral thrombus |
| 07/21/2004 | CN1158073C Application of protein kinase C inhibitor in preparing medicine |
| 07/20/2004 | US6765022 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists |
| 07/20/2004 | US6765019 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 07/20/2004 | US6765013 Thiazolidinedione derivatives for the treatment of diabetes and other diseases |
| 07/20/2004 | US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
| 07/20/2004 | US6765010 Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 07/20/2004 | US6765009 1,4-Disubstituted benzo-fused compounds |
| 07/20/2004 | US6765006 Antagonists of amino-3-hydroxy-5-methylisoxazole-4-propionic acid (ampa) ionotropic receptors; neurodegenerative, alzheimer's, and huntington's disease; amyotrophic lateral sclerosis; schizophrenia, excitatory amino acid deficiency |
| 07/20/2004 | US6765004 Anticoagulants, antiischemic and hypotensive agents; cardiovascular disorders, congestive heart failure, liver cirrhosis, renal vasospasm, renal failure, cerebral edema and ischemia, strokes |
| 07/20/2004 | US6765003 3-Arylsulfonyl-2 (substituted methyl) propanoic acid derivatives as matrix metalloproteinase inhibitors |
| 07/20/2004 | US6764826 Detcting modulators of c-reactive proteins; obtain c-reactive protein, incubate with modulator, monitor binding between reactive protein and modulator |
| 07/20/2004 | US6764683 Stimulation of hematopoiesis in patients undergoing cytotoxic cancer chemotherapy; preventing mucositis; cytoprotection |
| 07/20/2004 | CA2292388C Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 07/20/2004 | CA2257136C Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors |
| 07/20/2004 | CA2254731C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids |
| 07/20/2004 | CA2134972C Anti-ischemic medicament |
| 07/20/2004 | CA2085555C Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them |
| 07/15/2004 | WO2004058970A1 Adiponectin promoter and use thereof |
| 07/15/2004 | WO2004058790A1 Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof |
| 07/15/2004 | WO2004058772A1 Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same |
| 07/15/2004 | WO2004058770A1 Triptolide derivatives and their use |
| 07/15/2004 | WO2004058767A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 07/15/2004 | WO2004058745A1 Optically active dihydropyridine derivative |
| 07/15/2004 | WO2004058728A1 Novel ethylenediamine derivatives |
| 07/15/2004 | WO2004058682A1 Selective estrogen receptor modulators |
| 07/15/2004 | WO2004058354A1 Compositions of cyclooxygenase-2 selective inhibitors and selective serotonin reuptake inhibitors for the treatment or prevention of a vaso-occlusive event |
| 07/15/2004 | WO2004058275A2 Compositions of magnetic particles covered with gem-bisphosphonate derivatives |
| 07/15/2004 | WO2004058245A1 Tanshinone iia for prophylaxising or treating atherosclerosis |
| 07/15/2004 | WO2004045536A3 Method and compositions for temporarily incapaciting subjets |
| 07/15/2004 | WO2004041245A3 Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases |
| 07/15/2004 | WO2004032708A3 Vasoregulating compounds and methods of their use |
| 07/15/2004 | WO2004002535A8 Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis |
| 07/15/2004 | WO2003099226A3 Antibody peg positional isomers, compositions comprising same, and use thereof |
| 07/15/2004 | WO2003093422A3 Novel tissue factor targeted antibodies as anticoagulants |
| 07/15/2004 | WO2003092715A3 Proteins involved in the regulation of energy homeostasis |
| 07/15/2004 | WO2003092626A3 Carvedilol pharmasolve solvate |
| 07/15/2004 | WO2003092613A3 Catechin multimers as therapeutic drug delivery agents |
| 07/15/2004 | WO2003092588A3 4-azasteroid derivatives as androgen receptor modulators |
| 07/15/2004 | WO2003089608A3 Drg11-responsive (dragon) gene family |
| 07/15/2004 | WO2003087108A3 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
| 07/15/2004 | WO2003087040A3 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
| 07/15/2004 | WO2003070965A9 The eaat2 promoter and uses thereof |
| 07/15/2004 | WO2003065974A3 Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 07/15/2004 | WO2003063893B1 Fgfr agonists |
| 07/15/2004 | WO2003044162A3 Genes encoding g-protein coupled receptors and methods of use therefor |
| 07/15/2004 | WO2002081636A3 Protein modification and maintenance molecules |
| 07/15/2004 | US20040138462 Aminoalcohol derivatives |
| 07/15/2004 | US20040138454 Drugs for treating pain formed by arylation |
| 07/15/2004 | US20040138449 Antiviral agents |
| 07/15/2004 | US20040138430 Novel polypeptide compose substance for promoting blood and blood vessel cell growth |
| 07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
| 07/15/2004 | US20040138414 Secreted proteins |
| 07/15/2004 | US20040138300 Compounds |
| 07/15/2004 | US20040138291 Hypotensive therapy; administering angiotensin converting enzyme ( ACE) inhibitor such as enalapril, and dopaminergic agonist apomorphine or salt or ester thereof |
| 07/15/2004 | US20040138287 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors |
| 07/15/2004 | US20040138286 Rho kinase inhibitors |
| 07/15/2004 | US20040138281 Parkinson's and Huntington's disease; psychoses, impotence, renal or heart failure, schizophrenia |
| 07/15/2004 | US20040138278 Administering an angiontensin type 1 (AT1)receptor antagonist such as eprosartan |
| 07/15/2004 | US20040138277 Syndrome X, hyperglycemia, hyperlipidemia, obesity, atherosclerosis; anticoagulant, hypotensive, and antidiabetic agents; cardiovascular disorders |
| 07/15/2004 | US20040138276 Metalloproteinase inhibitors |
| 07/15/2004 | US20040138274 Novel pharmaceuticals |
| 07/15/2004 | US20040138273 Carbocycle based inhibitors of glycogen synthase kinase 3 |
| 07/15/2004 | US20040138264 Tetrahydropyridly-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 07/15/2004 | US20040138259 Pain management |
| 07/15/2004 | US20040138251 Anticancer agents; osteoporosis; polycystic kidney disease; antiarthritic agents; organ transplant rejection |
| 07/15/2004 | US20040138250 Inhibitors of cruzipain and other cysteine proteases |
| 07/15/2004 | US20040138229 Platelet adenosine diphosphate receptor antagonists |
| 07/15/2004 | US20040138227 Antiserotonine agents; antidepressants |